SCHEMBL22924152

SCHEMBL22924152

Cc1nn(CC(C)(C)c2c(F)ccc3cnn(C4CC4)c23)c2ccc(F)c(C(C)(C)C)c12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24592398 0.89 — —
SCHEMBL22328032 0.79 HTR1A (0.32) —
SCHEMBL24089391 0.72 HDAC4 (0.31) —
SCHEMBL18408663 0.71 MAPT (0.34) —
SCHEMBL22328033 0.70 EZH2 (0.35) —
SCHEMBL26578040 0.69 — —
SCHEMBL21662938 0.67 EZH2 (0.39) —
SCHEMBL22349112 0.67 HTR2A (0.34) —
SCHEMBL22924153 0.66 PROKR1 (0.32) —
SCHEMBL24089504 0.66 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210024501-A1 COVALENT INHIBITORS OF KRAS ARAXES PHARMA LLC 2021-01-28 — — US disclosed
Send feedback